Skip to main content
. 2024 Nov 17;7:321. doi: 10.1038/s41746-024-01324-0

Table 1.

Simulation result using deterministic input variables (simulation horizon of 5 years)

Treatment scenario Cumulated total direct costs base case [in EUR] Cumulated effectiveness base case [in QALY] Incremental net monetary benefit (INMB), comparator: Treatment 1 [in EUR] Incremental cost effectiveness ratio (ICER), comparator: Treatment 1 [EUR/QALY] Ranking treatment scenarios
Per patient Per cohort Per patient Per cohort
Treatment 1: Without DiGA scenario 7,933 ~39,482 million 2.16478 10,774,482 1
Treatment 2: With DiGA scenario standard of care 7,980 ~39,720 million 2.16538 10,777,473 -14.84 79,466 2
Treatment 3: With DiGA future scenario 9,469 ~47,130 million 2.18367 10,868,511 -501.43 81,335 3